• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI 0.00% 0.9¢

ALGORAE PHARMACEUTICALS LIMITED - News & Media

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No News & Media currently available.

(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $15.18M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $7.027K 780.3K

Buyers (Bids)

No. Vol. Price($)
1 35383 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 280097 1
View Market Depth
Last trade - 15.57pm 22/07/2024 (20 minute delay) ?
Last
0.9¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.9¢ 0.9¢ 0.9¢ 70215
Last updated 15.25pm 22/07/2024 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.